Objective:
To explore the evolving landscape of treatments for ocular surface disease (OSD) and dry eye disease (DED).
Key Findings:
- Rephrase for clarity and connection to treatments.
Interpretation:
The complexity of OSD necessitates a tailored approach to treatment, considering the multifactorial nature of the condition and the diverse therapeutic options available.
Limitations:
- Add a point regarding the lack of patient perspectives.
Conclusion:
The future of OSD treatment is promising, with advancements in targeted therapies and delivery systems expected to improve patient outcomes significantly.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.